| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962417 | Vaccine | 2016 | 4 Pages |
Abstract
Only a small percentage of the adolescent population is ineligible to receive the smallpox vaccine currently in use. This group may be protected by herd-immunity, or by new-generation vaccines designed to prevent severe adverse events.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Itay Fogel, Tal Brosh-Nissimov, Granit Vager, Yaron Aviv, Michael Kassirer,